| ||||||||||||||
|
|
|||||||||||||





From the Departments of *Anesthesiology and Intensive Care,
Biochemistry,
Cardiac Surgery, and
Pediatric Cardiology, Hospices Civils de Lyon, Louis Pradel Hospital and Claude Bernard Lyon 1 University, Lyon, France.
Address correspondence and reprint requests to Maxime Cannesson, Service d'Anesthésie Réanimation, Hôpital Cardiologique Louis Pradel, 200 avenue du Doyen Lépine, 69500 Bron, France. Address e-mail to maxime_cannesson{at}hotmail.com.
BACKGROUND: Plasma B-type natriuretic peptide (BNP) can predict postoperative complications after cardiac surgery in adults. Our aim was to investigate BNP kinetics and prognostic value in neonates undergoing the arterial switch operation (ASO) for transposition of the great arteries (TGA).
METHODS: We measured BNP concentrations in 30 neonates before, immediately after, and 6, 12, 24, and 48 h after ASO for TGA. Complicated postoperative evolution was defined as patients requiring mechanical ventilation or presenting low cardiac output syndrome for more than 72 h. We studied the ability of postoperative BNP concentrations to predict complicated evolution.
RESULTS: Intubation duration, inotropic support duration, and intensive care unit stay were 68 (48121) h, 78 (69141) h, and 96 (76149) h respectively. Patients with complicated evolution had higher 6 and 12-h BNP concentrations than patients with simple evolution (459 (210897) vs 137 (67248) ng/L and 547 (193868) vs 185 (79354) ng/L respectively; P < 0.05) and had longer intubation, inotropic support, and intensive care unit stay (96 (70190) vs 50 (4866) h, 100 (83190) vs 70 (5972) h, and 120 (90240) vs 84 (7296) h, P < 0.05). A 6-h BNP concentration >160 ng/L was able to predict complicated evolution with a sensitivity of 93% and a specificity of 67%.
CONCLUSION: In neonates, BNP concentrations can predict adverse outcome in the postoperative period after ASO for TGA. This marker has potential clinical applications.
This article has been cited by other articles:
![]() |
J T Attridge, D A Kaufman, and D S Lim B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2009; 94(3): F178 - F182. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Hsu, P. E. Oishi, R. L. Keller, O. Chikovani, T. R. Karl, A. Azakie, I. Adatia, and J. R. Fineman Perioperative B-type natriuretic peptide levels predict outcome after bidirectional cavopulmonary anastomosis and total cavopulmonary connection. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 746 - 753. [Abstract] [Full Text] [PDF] |
||||
|